POSTER SESSION V
Wednesday, March 11, 2009 — 9:30 AM - 12:00 Noon
Convention Center Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
92
PCA3: A Urine-Based Genetic Assay for Detection of Prostate Cancer in Men with Elevated PSA
(694)
ED Crawford, J Qian, K Drewnowska, S Varvel, M Wilk, L Mason, A Barqawi, J Kaminetsky, T Huisman, M Bilowus, S Freedman, DG Bostwick - Univ. of Colorado, Aurora, CO; Bostwick Laboratories, Glen Allen, VA; Univ. Urology Associates, New York, NY; Chiramonte Huisman Zorn Urology, Clinton, MD; Bilowus Medical, Reston, VA; Sheldon J Freedman, M.D., LTD, Las Vegas, NV
IFI16: A Novel Growth Suppressor in Human Prostate Cancer
(693)
HX Bui, JP Reynolds, GA Hill, R Panchananthan, D Choubey - VAMC and U of Cincinnati, Cincinnati, OH
Expression of the Notch Family of Proteins in Prostatic Adenocarcinomas: Notch2 Signaling Is Associated with High Tumor Grade, Advanced Stage and Biochemical Disease Recurrence
(789)
BVS Kallakury, GM Sheehan, CE Sheehan, JS Ross - Georgetown University Hospital, Washington, DC; Albany Medical College, Albany, NY
Association and Significance of Myc, Estrogen Receptor, and Metastasis-Associated Gene 1 Expression in Advanced Prostate Cancer
(781)
MD Hofer, D Pflueger, S Perner, R Kim, F Demichelis, R Kuefer, MA Rubin - Brigham and Women's Hospital, Boston, MA; Weill Cornell Medical College, New York, NY; University of Ulm, Ulm, Germany
EPHB2 Alterations in Prostate Carcinoma: Evaluation of Mutational Status in a Large Series of Prostate Carcinoma Tissues and Cell Lines
(706)
A Andea, L Chen, Y Xiao, W Gerald - UAB, Birmingham, AL; MSKCC, New York, NY
Chromosomal Deletions at 6q, 8p, and 13q in the Early Development of Prostate Cancer
(886)
H Takahashi, M Nakano, M Furusato, H Hano - The Jikei University School of Medicine, Minato-ku, Tokyo, Japan
Expression of Extracellular Matrix Associated Protein Cyr61 in Prostate Cancer: An Immunohistochemical and Quantitative RT-PCR Analysis
(894)
A Toubaji, KB D'Antonio, R Albadine, AM Mondul, EA Platz, RH Getzenberg, GJ Netto - Johns Hopkins University School of Medicine, Baltimore, MD; Johns Hopkins Bloomberg School of Public Health
Estrogen Receptor-alpha and - beta Expression in the Stroma Associated with Adenocarcinoma of the Prostate
(766)
LL Gellert, S Dahiya, J Melamed, L Chiriboga, D Hatcher, YR Li, SM Ho, YK Leung, P Lee - New York University, New York, NY; University of Cincinnati, Cincinnati, OH
Prostate Atrophy, but Not Prostate Carcinoma, Is Characterised by a Relative Infiltration of Tregs
(772)
B Gurel, A Valdman, L Cappelli, K Tsilidis, J Hicks, AM De Marzo, CG Drake, AK Meeker - The Johns Hopkins University School of Medicine, Baltimore, MD; The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Different Immunohistochemical Expression of CD44v6 and ALDH1 in Prostate Cancer before and after Androgen Deprivation Therapy
(902)
SA Umar, M Fiorentino, C Magi-Galluzzi, D Bailey, C Fiore, R Montironi, M Loda - Brigham and Women's Hospital, Boston, MA; Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic Foundation, Cleveland, OH; University of Ancona, Ancona, Italy
EAAC1 Aspartate Transporter Expression in Normal, Hyperplastic and Neoplastic Human Prostate Gland
(744)
MM Desouki, MT Smith, LC Costello, RB Franklin - MUSC, Charleston, SC; Dental School, University of Maryland, Baltimore, MA
Immunohistochemical Expression of BRCA1 in Prostate Cancer
(760)
M Fiorentino, L Mucci, K Fall, D Bailey, C Fiore, G Judson, O Andren, SO Andersson, M Loda - Dana-Farber Cancer Institute, Boston, MA; Harvard School of Public Health, Boston, MA; University of Orebro, Orebro, Sweden
Tissue Factor Expression in Prostate Cancer Using a Matched Case-Control Outcome-Based TMA Design Set
(817)
V Macias, Y Lu, W Liang, W Gao, CA Beam, A Balla, PF Lindholm - University of Illinois at Chicago, Chicago, IL; Northwestern University, Chicago, IL
Rhabdomyosarcoma of the Urinary Bladder and Prostate in Adults: A Clinicopathologic Study of 11 Cases
(806)
M Liang, P Troncoso, BA Czerniak, CC Guo - UT MD Anderson Cancer Center, Houston, TX
Nested Urothelial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases
(912)
MJ Wasco, D Bradley, RB Shah - University of Michigan, Ann Arbor, MI
Lipoid-Cell Variant of Urothelial Carcinoma: A Neoplasm with True Lipid and Its Association with Micropapillary Carcinoma
(883)
Y Suarez, M Idress, G Xiao, R Gordon, L Miller, P Unger - Mount Sinai Medical Center, New York, NY
Immunohistochemical Analysis of Urachal Carcinoma with Emphasis on Its Morphologic Types and Their Differential Diagnosis with Metastatic Colonic Adenocarcinoma: Diagnostic Role of Traditional and Novel Markers
(850)
GP Paner, JK McKenney, JL Yao, WL Frankel, SS Shen, RE Jimenez - Loyola University Medical Center, Maywood, IL; The Mayo Clinic, Rochester, MN
P16 Expression in Small Cell Carcinoma of the Urinary Bladder
(724)
N Buza, A Finkelstein, P Hui, P Cohen, V Parkash - Yale University School of Medicine, New Haven, CT
Urothelial Carcinoma Associated with Clinically Diagnosed Prostatic Adenocarcinoma
(762)
TA Flood, BN Nguyen, EC Marginean, BM Purgina, KT Mai - The University of Ottawa, Ottawa, ON, Canada; The Ottawa Hospital, Ottawa, ON, Canada
Are Nephrogenic Adenomas Renal Stem/Progenitor Cell-Derived Lesions? An Immunohistochemical Study
(745)
KM Devaraj, M Castillo-Martin, HS Tian, D Hamele-Bena, G-X Tong - Columbia University Medical Center, New York, NY
Extent of Prostatic Atrophy in Needle Biopsies and Serum PSA Elevation: Is There an Association with the Type of Atrophy?
(716)
A Billis, L Meirelles, LLL Freitas, F Rogerio, RV Oliveira, L Schultz, MG Fazuoli, MN Bronner, LA Magna - School of Medicine, University of Campinas (Unicamp), Campinas, SP, Brazil
Prostate Cancer Topography and Patterns of Lymph Node Metastasis
(892)
Y Tokuda, M Kaag, A Gopalan, SK Tickoo, B Guillonneau, JA Eastham, PT Scardino, HI Scher, VE Reuter, SW Fine - Memorial Sloan-Kettering Cancer Center, New York, NY
Variation among Urogenital Pathologists in Diagnostic Opinion of Single Small Atypical Foci in Prostate Biopsies
(904)
TH Van der Kwast, A Evans, G Lockwood, D Tkachuk, K Watson, DG Bostwick, JI Epstein, P Humphrey, R Montironi, J Srigley, Members of the Pathology Committee of the ERSPC - University Health Network, Toronto, Canada; Bostwick Laboratories, Glen Allen; Johns Hopkins Hospital, Baltimore; Washington University School of Medicine, St. Louis; Polytechnic University of the Marche Region, Ancona, Italy; Credit Valley Hospital, Mississauga, Canada
Can Saturation Biopsy Predict Significant Cancer Nodule Localization in Radical Prostatectomy Specimens: A Correlative Study and Implications for Focal Therapy for Prostate Cancer
(758)
SM Falzarano, M Zhou, E Kodjoe, M Gong, JS Jones, C Magi-Galluzzi - Cleveland Clinic, Cleveland; Glickman Urological Institute, Cleveland, OH
Interobserver Variability in Histologic Evaluation of Radical Prostatectomy between Central Pathologists and Local Pathologists: Findings of a Multinational Clinical Trial
(843)
GJ Netto, JI Epstein - Johns Hopkins University, Baltimore, MD
Prostate Biopsy Cannot Reliably Identify Patients for Focal Therapy: Correlations of Low-Risk Prostate Cancer on Biopsy with Radical Prostatectomy Findings
(858)
P Quann, D Jarrard, W Huang - University of Wisconsin, Madison, WI
Characterization of Gleason Grade 3 Tumor in Localized and Advanced Prostatic Adenocarcinoma Using a Panel of Functional Gene Expression Markers
(714)
C Barrett, P Smyth, B Loftus, O Sheils, JJ O'Leary - Trinity College Dublin, Dublin, Ireland; Adelaide & Meath Hospital, Dublin, Ireland
Significance of Tertiary Pattern 5 in Prostate Needle Biopsies with Gleason Score of 3+4 or 4+3 Prostate Cancer: Pathologic Correlation Following Radical Prostatectomy
(873)
RB Shah, S Daignault, LP Kunju, DP Wood, Jr, JT Wei - University of Michigan, Ann Arbor, MI
Methods of Submitting Cores and Gleason Score as Contributory Factors to the Fragmentation of Prostate Core Biopsies Containing Adenocarcinoma
(756)
DF Fajardo, JI Epstein - Johns Hopkins Hospital, Baltimore, MD
Cancer to Prostatic Urethra Distance in Radical Prostatectomy: Implications for Urethral Thermoprotection in Prostate Cryoablation Surgery
(818)
C Magi-Galluzzi, S Jones, AV Hernandez, M Zhou - Cleveland Clinic, Cleveland, OH
Trend of Radical Prostatectomy and Clinical Pathologic Features of Prostate Cancer: Experience from a Single Tertiary Hospital in the Last Ten Years
(769)
JM Gonzalez-Berjon, JY Ro, TM Wheeler, QH Zhai, AG Ayala, SS Shen - The Methodist Hospital and Research Institute, Houston; Baylor College of Medicine, Houston, TX
Correlation of Gleason Score and Tumor Size with Magnetic Reasonance Image-Detected Prostate Cancer
(767)
EM Genega, NB Bloch, W Dewolf, R Elliot, Y Fu, M Sanda, J Tomaszewski, N Rofsky - Beth Israel Deaconess Medical Center, Boston, MA; University of Pennsylvania, Philadelphia, PA
Tumor Volume in Radical Prostatectomy Specimens: Is It an Independent Prognostic Factor for Biochemical (PSA) Progression Following Surgery?
(717)
A Billis, L Meirelles, LLL Freitas, AGE Duarte, CAM Silva, MAM Bisson, LA Magna, U Ferreira - School of Medicine, University of Campinas (Unicamp), Campinas, SP, Brazil
What Are the Best Preoperative Predictors of Tumour Volume on Radical Prostatectomy?
(877)
D Sidhu, J Zhang, A Yilmaz, K Trpkov - Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada
button next to any title to add to Itinerary Planner...
Add
